Search Results - Aurélien Marabelle

Refine Results
  1. 1
    CAR-T cells and BiTEs in solid tumors: challenges and perspectives

    CAR-T cells and BiTEs in solid tumors: challenges and perspectives by Julien Edeline, Roch Houot, Aurélien Marabelle, Marion Alcantara

    Published 2021-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?

    Immune checkpoint-targeted antibodies: a room for dose and schedule optimization? by Christophe Maritaz, Sophie Broutin, Nathalie Chaput, Aurélien Marabelle, Angelo Paci

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer

    A microsimulation model to assess the economic impact of immunotherapy in non-small cell lung cancer by Clémence Legoupil, Didier Debieuvre, Aurelien Marabelle, Stefan Michiels, Raïssa Kapso, Benjamin Besse, Julia Bonastre

    Published 2020-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy

    755 DEKA-1 a dose-finding Phase 1 trial: observing safety and biomarkers using DK210 (EGFR) for inoperable locally advanced and/or metastatic EGFR+ tumors failing systemic therapy... by Aurélien Marabelle, John Mumm, Douglas Orr, Alexander I Spira, Elizabeth C Moser, Deb Kientop

    Published 2023-11-01
    Article
    Save to List
    Saved in:
  5. 5
    In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CAR-Spacer

    In Vitro and In Vivo Comparison of Lymphocytes Transduced with a Human CD16 or with a Chimeric Antigen Receptor Reveals Potential Off-Target Interactions due to the IgG2 CH2-CH3 CA... by Béatrice Clémenceau, Sandrine Valsesia-Wittmann, Anne-Catherine Jallas, Régine Vivien, Raphaël Rousseau, Aurélien Marabelle, Christophe Caux, Henri Vié

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?

    Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation? by Selma Addou, Clémentine Sarkozy, Julien Lazarovici, Stéphane Champiat, Aspasia Stamatoullas, Fabrice Jardin, Vincent Ribrag, Aurélien Marabelle, Jean-Marie Michot

    Published 2021-10-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Organizational Impact of Immunotherapies in Advanced Cancers in France

    Organizational Impact of Immunotherapies in Advanced Cancers in France by Valentine Grumberg, Christos Chouaïd, Anne-Françoise Gaudin, Christophe Le Tourneau, Aurélien Marabelle, Isabelle Bongiovanni-Delarozière, François-Emery Cotté, Isabelle Borget

    Published 2023-08-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody

    315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody by Aurélien Marabelle, Carlos Gomez-Roca, Pierre Ferre, Eric Chetaille, Aurelie Petain, Celine Thuilliez, Isabelle Vandenberghe, Francisco Cruzalegui, Asmaa Boudribila, Mariya Pavlyuk

    Published 2020-11-01
    Article
    Save to List
    Saved in:
  9. 9
    Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

    Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors by Stephane Champiat, Francois-Xavier Danlos, Aurélien Marabelle, Yohann Loriot, Julia Delahousse, Kaïssa Ouali, Santiago Ponce, Laurent Mathiot, David Combarel, Justin Cagnat, Sophie Broutin

    Published 2024-05-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A

    316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A by Aurélien Marabelle, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Paul Frohna, Christiane Jungels, Norbert Vey, Elena Garralda, Marina Iché

    Published 2020-11-01
    Article
    Save to List
    Saved in:
  11. 11
    484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors

    484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors by Stephane Champiat, Aurélien Marabelle, Aung Naing, Filip Janku, Patricia LoRusso, David Béchard, Elena Garralda, Vladimir Galvao, Peter Grell, Richard Sachse, Joachim Kiemle-Kallee

    Published 2021-11-01
    Article
    Save to List
    Saved in:
  12. 12
    Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice

    Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice by Aurélien Marabelle, Louis Meyblum, Lambros Tselikas, Thierry de Baere, Sandrine Susini, Fréderic Deschamps, Baptiste Bonnet, Céline Chevaleyre, Benoit Jego, Dimitri Kereselidze, Vincent Lebon, Charles Truillet

    Published 2023-11-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy

    Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy by Aurélien Marabelle, Samy Ammari, Eric Deutsch, Michael Farwell, Heiko Schöder, Lawrence H Schwartz, Binsheng Zhao, Laurent Dercle, Jeremy McGale, Shawn Sun, Randy Yeh, Fatima-Zohra Mokrane

    Published 2022-09-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

    Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors by Ben Tran, Richard D. Carvajal, Aurelien Marabelle, Sandip Pravin Patel, Patricia M. LoRusso, Erik Rasmussen, Gloria Juan, Vijay V. Upreti, Courtney Beers, Gataree Ngarmchamnanrith, Patrick Schöffski

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

    CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers by Francois-Xavier Danlos, Aurélien Marabelle, Roberto Ferrara, Benjamin Besse, Lydie Cassard, Nathalie Chaput, Aude Desnoyer, Boris Duchemann, Marie Naigeon, Edouard Auclin, Jean-Mehdi Jouniaux, Lisa Boselli, Jonathan Grivel, Laura Mezquita, Caroline Caramella

    Published 2022-02-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types

    Evidence of pseudoprogression in patients treated with PD1/PDL1 antibodies across tumor types by Patricia Martin‐Romano, Eduardo Castanon, Samy Ammari, Stéphane Champiat, Antoine Hollebecque, Sophie Postel‐Vinay, Capucine Baldini, Andrea Varga, Jean Marie Michot, Perrine Vuagnat, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté, Christophe Massard

    Published 2020-04-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer

    Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer by Caroline Robert, Aurélien Marabelle, Fabrice Barlesi, Samy Ammari, David Planchard, Siham Farhane, Paul-Henry Cournède, Pierre Decazes, Younes Belkouchi, Léo Mottay, Littisha Lawrance, Antoine de Prévia, Hugues Talbot, Florian Guisier, Tony Ibrahim, Pierre Vera, Nathalie Lassau

    Published 2023-09-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?

    Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker? by Patricia Martin-Romano, Julien Adam, Jean-Yves Scoazec, Sébastien Gouy, Antonin Levy, Capucine Baldini, Stéphane Champiat, Jean-Charles Soria, Jean-Charles Soria, Jean-Charles Soria, Christophe Massard, Aurélien Marabelle, Eric Deutsch, Eric Deutsch, Eric Deutsch, Antoine Hollebecque

    Published 2021-11-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers

    Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers by Tiphaine Lambert, Cedric Pobel, Léo Colmet-Daage, Amélie Bigorgne, Brice RaubyY, Nicolas Sanchez-Escobar Aladro, Lucile Ter-MinassianN, Marie Kerisit, Aurélien Marabelle, Benjamin Besse, Antoine Hollebecque, Stéphane Champiat, Christophe Massard, Daphné Morel, Loic Velringue, Jean-Yves Scoazec

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.

    Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN. by Anne Guimier, Sandrine Ferrand, Gaëlle Pierron, Jérôme Couturier, Isabelle Janoueix-Lerosey, Valérie Combaret, Véronique Mosseri, Estelle Thebaud, Marion Gambart, Dominique Plantaz, Aurélien Marabelle, Carole Coze, Xavier Rialland, Sylvie Fasola, Eve Lapouble, Paul Fréneaux, Michel Peuchmaur, Jean Michon, Olivier Delattre, Gudrun Schleiermacher

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: